Press Releases ALL > Press Release - 2024-04-18 Other PureTech Health: Notice of Results Continue Press Release - 2024-04-16 Wholly Owned Pipeline - LYT-100 Other PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis Continue Press Release - 2024-04-11 Gallop Oncology – LYT-200 PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers Continue Publications ALL > Publications 2024-03-04 Validating the efficacy and value proposition of mental fitness vocal biomarkers in a psychiatric population: prospective cohort study Full Article Publications 2023-04-15 VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection Full Article Publications 2022-04-13 Cell Host & Microbe: Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers Full Article @PureTechH Tweets by PureTechH
Press Releases ALL > Press Release - 2024-04-18 Other PureTech Health: Notice of Results Continue Press Release - 2024-04-16 Wholly Owned Pipeline - LYT-100 Other PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis Continue Press Release - 2024-04-11 Gallop Oncology – LYT-200 PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers Continue Publications ALL > Publications 2024-03-04 Validating the efficacy and value proposition of mental fitness vocal biomarkers in a psychiatric population: prospective cohort study Full Article Publications 2023-04-15 VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection Full Article Publications 2022-04-13 Cell Host & Microbe: Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers Full Article @PureTechH Tweets by PureTechH
